Richard Newitter
Stock Analyst at Truist Securities
(4.16)
# 451
Out of 4,944 analysts
379
Total ratings
49.34%
Success rate
13.59%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Downgrades: Hold | $111 → $63 | $52.29 | +20.48% | 19 | Aug 12, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $190 → $125 | $84.92 | +47.20% | 26 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Hold | $410 → $415 | $375.00 | +10.67% | 21 | Aug 4, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $18 → $21 | $14.75 | +42.37% | 2 | Jul 30, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $145 → $137 | $108.84 | +25.87% | 8 | Jul 25, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $82 | $76.70 | +6.91% | 19 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $120 → $125 | $101.92 | +22.65% | 17 | Jul 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $600 | $475.03 | +26.31% | 29 | Jul 23, 2025 | |
| TNDM Tandem Diabetes Care | Initiates: Hold | $24 | $11.61 | +106.72% | 1 | Jun 16, 2025 | |
| DXCM DexCom | Initiates: Buy | $102 | $80.54 | +26.65% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $310.61 | +17.51% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $61.91 | +9.84% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $121.10 | +13.13% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 → $135 | $91.71 | +47.20% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $39.45 | +77.44% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $36.63 | +39.23% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $6.78 | +18.08% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $92.16 | -2.34% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $20.09 | +19.46% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $13.89 | +36.79% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $165.40 | -12.33% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $102.29 | +10.47% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $252.44 | +12.90% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.73 | +33.50% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.98 | +150.63% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $86.73 | -5.45% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $194.00 | +28.87% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.90 | +430.61% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $144.04 | +434.57% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $68.30 | +24.45% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.92 | +54.80% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $14.07 | +91.90% | 5 | Feb 23, 2021 |
Lantheus Holdings
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $52.29
Upside: +20.48%
Inspire Medical Systems
Aug 5, 2025
Downgrades: Hold
Price Target: $190 → $125
Current: $84.92
Upside: +47.20%
Stryker
Aug 4, 2025
Maintains: Hold
Price Target: $410 → $415
Current: $375.00
Upside: +10.67%
Beta Bionics
Jul 30, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.75
Upside: +42.37%
Integer Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $145 → $137
Current: $108.84
Upside: +25.87%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $81 → $82
Current: $76.70
Upside: +6.91%
Boston Scientific
Jul 24, 2025
Maintains: Buy
Price Target: $120 → $125
Current: $101.92
Upside: +22.65%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $590 → $600
Current: $475.03
Upside: +26.31%
Tandem Diabetes Care
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $11.61
Upside: +106.72%
DexCom
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $80.54
Upside: +26.65%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $310.61
Upside: +17.51%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $61.91
Upside: +9.84%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $121.10
Upside: +13.13%
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $91.71
Upside: +47.20%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $39.45
Upside: +77.44%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $36.63
Upside: +39.23%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $6.78
Upside: +18.08%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $92.16
Upside: -2.34%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $20.09
Upside: +19.46%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $13.89
Upside: +36.79%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $165.40
Upside: -12.33%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $102.29
Upside: +10.47%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $252.44
Upside: +12.90%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.73
Upside: +33.50%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.98
Upside: +150.63%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $86.73
Upside: -5.45%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $194.00
Upside: +28.87%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.90
Upside: +430.61%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $144.04
Upside: +434.57%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $68.30
Upside: +24.45%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.92
Upside: +54.80%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $14.07
Upside: +91.90%